(MENAFNEditorial) Zion Market Research has published a new report titled 'Rheumatology Therapeutics Market by Disease Type (Rheumatoid Arthritis, Osteoarthritis, Lupus, Gout, Ankylosing spondylitis and other), Drug Type (NSAIDs, Analgesics, DMARDs, Corticosteroids and Other), Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals). According to the report, the global was valued at around USD 44.18 billion in 2017 and is expected to reach around USD 50.9 billion by 2022, growing at a CAGR of 2.9 % between 2016 and 2022.
Musculoskeletal conditions are a major burden on the individual, society and the healthcare service providers. These conditions result in joint inflammation, pain, swelling, and stiffness. Rheumatic disease is one of the leading causes of morbidity in around the world. People of all ages, genders, and races can have arthritis, and it is the leading cause of disability in the United States. More than 50 million adults and almost 300,000 children have arthritis or some other type of rheumatic disease. Rheumatic diseases are generally common among women and occur more frequently as people get older.
Browse the full "Rheumatology Therapeutics Market by Disease Type (Rheumatoid Arthritis, Osteoarthritis, Lupus, Gout, Ankylosing spondylitis and other), Drug Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Disease Modifying Anti-Rheumatic Drugs (DMARDs), Corticosteroids and Others), Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 2022.: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 2022." report at
The growing burden of rheumatic diseases around the world is fostering the growth of rheumatology therapeutics market. A wide number of biosimilars and drugs under pipeline are fostering the growth of the market. However, high capital investments in drug development, stringent rules and regulations are slowing the growth of the market. Technologically enhanced products such as biologics and biosimilars are expected to present lucrative business opportunities in future.
On the basis of disease type, the global rheumatology therapeutics market is divided into rheumatoid arthritis, osteoarthritis, lupus, gout, ankylosing spondylitis and other. Rheumatoid arthritis disease has high prevalence rates than other disease and accounts for the major share in global rheumatology therapeutics market. On the basis of drug type the market is segmented into non-steroidal anti-inflammatory drugs, analgesics, disease modifying anti-rheumatic drugs, corticosteroids and other. DMARDs segment dominated the market in 2016 owing to their increased in use in the early stage of treatment. The distribution channel segment of rheumatology therapeutics includes a retail pharmacy, online pharmacy, and hospitals.
The global rheumatology therapeutics market was dominated by North America and it held maximum share of total revenue generated in 2016. The growth in this region is attributed to the increased geriatric population and soaring capital investments in the pharma sector. Europe is another leading regional market followed by North America. Growing incidences of rheumatoid diseases and advanced healthcare infrastructure is accounting the growth in this region. Asia Pacific is the fastest growing market and is expected to show strong growth in forecast period. The growth in this region is primarily driven due to increasing geriatric population in countries like China and India. Japan is also accounting for key share in Asia Pacific market owing to presence of elderly population. Latin America is an emerging market due to rising healthcare infrastructure in this region.
Some of the key players operating in the rheumatology therapeutics market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Takeda Pharmaceutical and Sanofi.
This report segments the rheumatology therapeutics market as follows:
Global Rheumatology Therapeutics Market: Disease Type Analysis
- Rheumatoid Arthritis
- Osteoarthritis
- Lupus
- Gout
Global Rheumatology Therapeutics Market: Drug Type Analysis
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Analgesics
- Disease Modifying Anti-Rheumatic Drugs (DMARDs)
- Corticosteroids
- Others
Global Rheumatology Therapeutics Market: Distribution Channel Analysis
- Retail Pharmacy
- Online Pharmacy
- Hospitals
- Other
Global Rheumatology Therapeutics Market: Regional Analysis
- North America
- The U.S.
- Canada
- Rest of North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Qatar
- Rest of Middle East and Africa
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
MENAFN301602201800490000ID1096407529
--MENAFN301602201800490000ID1096407529-->
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.